Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06884059 · ClinicalTrials.gov registry record · Phase 1
Time Restricted Eating in Patients With Microalbuminuria
A Phase 1 study, sponsored by University of California, San Diego.
- Not yet
- Registry status
- Phase 1
- Development phase
- 25
- Enrollment target
NCT06884059 is a Phase 1 study that has not yet begun recruiting, run by University of California, San Diego. The registered enrollment target is 25 participants.
The verdict
NCT06884059, a Phase 1 study, has not yet begun recruiting, sponsored by University of California, San Diego.
- NOT YET RECRUITING
- Registry status
- Phase 1
- Development phase
- 25 participants
- Enrollment target
Study Summary
This is a clinical trial to assess how time-restricted eating (TRE) may improve kidney health and filtration patients with type 2 diabetes and increased protein content in their urine. All participants will be participating in TRE in which they follow a consistent 8-10 hour eating window everyday.
Interventions
- BEHAVIORAL Time Restricted Eating
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2025-03 |
| Est. Completion | 2028-02 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06884059
The ClinicalTrials.gov registry entry for NCT06884059 describes a study currently listed as not yet recruiting, categorized as Phase 1. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Time Restricted Eating is the first listed.
NCT06884059 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06884059 about?
NCT06884059 is a clinical study titled "Time Restricted Eating in Patients With Microalbuminuria". This is a clinical trial to assess how time-restricted eating (TRE) may improve kidney health and filtration patients with type 2 diabetes and increased protein content in their urine. All participants will be participating in TRE in which they follow a consistent 8-10 hour eating window everyday.
What is the current status of trial NCT06884059?
This trial is currently not yet recruiting. It is a Phase 1 study. The enrollment target is 25 participants. The study started on 2025-03. Estimated completion is 2028-02.
What interventions are being tested in trial NCT06884059?
The interventions under investigation include: Time Restricted Eating (BEHAVIORAL).
Who is sponsoring clinical trial NCT06884059?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.